A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

ZURICH, June 8 (Reuters) - Swiss pharmaceutical giant Roche has entered an exclusive licensing and collaboration agreement ...

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

Pancreatic cancer advocates in New Mexico say a new treatment could be a major breakthrough for people with the disease and ...

An FDA-approved vitamin D receptor agonist may help break the dense matrix surrounding pancreatic cancer tumors safely, ...

Prices of cisplatin and carboplatin widely used chemotherapy medicines may rise by 10-50% after manufacturers cited soaring ...

Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...

June 8 (Reuters) - Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks ...

The federal government is partnering with Innova Healthcare to strengthen cancer care, expand treatment access in Nigeria and ...